These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26611377)

  • 1. A rational approach to single, dual and triple therapy in COPD.
    Calverley P; Vlies B
    Respirology; 2016 May; 21(4):581-9. PubMed ID: 26611377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple therapy for the management of COPD: a review.
    Gaebel K; McIvor RA; Xie F; Blackhouse G; Robertson D; Assasi N; Hernandez P; Goeree R
    COPD; 2011 Jun; 8(3):206-43. PubMed ID: 21513437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilators: current and future.
    Cazzola M; Matera MG
    Clin Chest Med; 2014 Mar; 35(1):191-201. PubMed ID: 24507846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
    Petite SE
    Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal treatment of chronic obstructive pulmonary disease: the search for the magic combination of inhaled bronchodilators and corticosteroids.
    Criner GJ
    Ann Intern Med; 2007 Apr; 146(8):606-8. PubMed ID: 17438320
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhaled therapy for stable chronic obstructive pulmonary disease.
    Antoniu SA; Mihaescu T; Donner CF
    Expert Opin Pharmacother; 2007 Apr; 8(6):777-85. PubMed ID: 17425473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tiotropium and other long acting bronchodilators in chronic obstructive pulmonary disease.
    Currie GP; Rossiter C; Miles SA; Lee DK; Dempsey OJ
    Pulm Pharmacol Ther; 2006; 19(2):112-9. PubMed ID: 15970450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
    Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D
    Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
    Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ;
    Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled steroids and mortality in COPD: bias from unaccounted immortal time.
    Kiri VA; Vestbo J; Pride NB; Soriano JB
    Eur Respir J; 2004 Jul; 24(1):190-1; author reply 191-2. PubMed ID: 15293626
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF
    Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2195-7. PubMed ID: 17969568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple therapy trials in COPD: a precision medicine opportunity.
    Suissa S; Ariel A
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30545959
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.
    Pelaia G; Muzzio CC; Vatrella A; Maselli R; Magnoni MS; Rizzi A
    Expert Opin Pharmacother; 2015; 16(13):2009-21. PubMed ID: 26194120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease--a treatable disease.
    Osthoff M; Jenkins C; Leuppi J
    Swiss Med Wkly; 2013; 143():w13777. PubMed ID: 23592218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of combining inhaled drugs for COPD.
    Bjerg A; Lundbäck B; Lötvall J
    Curr Opin Pharmacol; 2012 Jun; 12(3):252-5. PubMed ID: 22465638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.